COMMUNIQUÉS West-GlobeNewswire

60 Degrees Pharmaceuticals Announces Date for Hospitalized Babesiosis Study Interim Data Release and Key Opinion Leader Webinar
01/10/2026
Interim analysis results from clinical study evaluating tafenoquine in severe babesiosis ( NCT06207370 ) to be disclosed on October 6, 2026. Key Opinion Leader investor webinar scheduled for October 6, 2026, featuring [...]
ViCentra Presents Large-Scale Real-World Evidence Demonstrating Kaleido Insulin Patch Pump System Delivers Stable Glucose Control with Very Low Hypoglycemia
01/10/2026
Analysis of 3,918 adults across Germany, the Netherlands and France, with no eligibility criteria beyond active system use, covering 323,814 person-days of real-world experience Users achieved median time in range of 72 [...]
SpyGlass Pharma Acquires Advanced Vision Science, Inc. (AVS), Securing Scalable Commercial IOL Supply and Accelerating Lens Portfolio Expansion Capability
01/10/2026
SpyGlass Pharma acquires 100% of the outstanding shares of AVS, a subsidiary of Santen Pharmaceutical Co., Ltd. (Santen), the existing manufacturer of SpyGlass Pharma’s intraocular lens (IOL) Secures scalable commercial [...]
Life Biosciences to Present First-in-Human Data from Ongoing Phase 1 Trial Evaluating ER-100 in Optic Neuropathies at Eyecelerator 2026
01/10/2026
BOSTON, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Life Biosciences (“Life Bio”), a biotechnology company pioneering cellular rejuvenation medicines to reverse diseases of aging, today announced that the company will present new [...]
HealthLynked Selects DRCARE247 as Telemedicine Partner to Expand Integrated Virtual Care Platform
01/10/2026
NAPLES, Fla., Oct. 01, 2026 (GLOBE NEWSWIRE) -- via IBN -- HealthLynked Corp. (OTCQB: HLYK ), a healthcare technology company focused on AI-powered patient engagement, care coordination, and provider connectivity, today [...]
Alignment Health Expands Access to Personalized Senior Care in 2027 with New Markets, Provider Networks and Medicare Advantage Plan Options
01/10/2026
Alignment Health expands into San Antonio, Charlotte and California's Central Valley, bringing its high-tech, high-touch care model to nearly 9.5 million Medicare-eligible seniors across five states ORANGE, Calif., Oct [...]
Balt Announces First Patients Enrolled in Silk Vista Baby™ PIONEER Study
01/10/2026
IRVINE, Calif., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Balt announced today it has enrolled the first patients in North America in the premarket approval (PMA) clinical trial, PIONEER ( PI votal Study O f the Silk Vista Baby [...]
Taysha Gene Therapies Announces Multiple Encore Presentations Supporting TSHA-102 Rett Syndrome Clinical Program at the 55th Child Neurology Society Annual Meeting
01/10/2026
DALLAS, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies [...]
Orchestra BioMed Exceeds Full Enrollment Target in the BACKBEAT Global Pivotal Trial of AVIM Therapy
01/10/2026
330 patients randomized as of September 30, 2026, surpassing full trial enrollment target Company reiterates prior guidance: primary endpoint data to be submitted for late-breaking presentation consideration at a major [...]
Clover Health’s 2027 Medicare Advantage Plans Emphasize PPO Choice, Preventive Care and Member Value
01/10/2026
Clover’s portfolio combines high-choice PPO access and meaningful member benefits with a Clover Assistant-powered care model WILMINGTON, Del., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: [...]
Teal Lights and Shared Stories: The Facial Pain Association Marks Facial Pain Awareness Month This October
01/10/2026
Landmarks worldwide will glow teal in solidarity. The month also features patient stories, educational resources, and ways for everyone to get involved SUWANEE, Ga., Oct. 01, 2026 (GLOBE NEWSWIRE) -- October is Facial [...]
Stryker to announce third quarter 2026 financial results
01/10/2026
Portage, Michigan, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) will host a webcast at 4:30 p.m. (Eastern time) on Thursday, October 29, 2026, to discuss its third quarter 2026 financial results. The live [...]
Daxor to Showcase Next-Gen Blood Volume Analyzer and New Clinical Data at HFSA 2026
01/10/2026
FDA 510(k)-cleared next-generation diagnostic platform delivers 3x faster results with 50% less blood, setting a new standard for data-driven heart failure management. Key Highlights: Commercial Acceleration: Daxor to [...]
Belite Bio Announces Oral Presentations at Two Upcoming Medical Conferences
01/10/2026
SAN DIEGO, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Belite Bio , Inc (NASDAQ: BLTE) (“Belite Bio ® ” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative [...]
Aktis Oncology Initiates Second Phase 1b Clinical Trial for AKY-2519, a Miniprotein Radioconjugate Targeting B7-H3
01/10/2026
Phase 1b BActinium-2 clinical trial is evaluating AKY-2519 in patients with non-small cell lung cancer (NSCLC) and other B7-H3 expressing tumors Enrollment is ongoing in the Phase 1b BActinium-1 clinical trial of AKY- [...]
Helus Pharma Announces Completion of Legal Name Change
01/10/2026
NEW YORK and TORONTO, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Helus Pharma (Nasdaq: HELP) (Cboe CA: HELP) (“Helus” or the “Company”), a clinical-stage pharmaceutical company committed to helping minds heal by developing novel [...]
Artiva Biotherapeutics Highlights Updated AlloNK® Data in Sjögren Disease Presented at the 17th International Symposium on Sjögren’s Disease (ISSjD 2026)
01/10/2026
Oral presentation includes safety and efficacy data as of the July 2, 2026 data cutoff, highlighting clinically meaningful improvements in disease activity and symptoms at six months in 11 patients with longstanding, [...]
Wave Life Sciences Announces FDA Feedback Supports Registrational Pathway for WVE-006 (RNA Editing) in AATD
01/10/2026
Following meeting with FDA, Wave plans for a single, two-year registrational trial, with a one-year interim analysis for potential accelerated approval based on AATD biomarkers WVE-006 (RNA editing) has potential to [...]
Arbutus Announces Final Results of Its US$230 Million Modified “Dutch Auction” Tender Offer
01/10/2026
WARMINSTER, Pa., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company focused on infectious disease, today announced the [...]

Pages